Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9

Toyoaki Hida, Takashi Seto, Hidehito Horinouchi, Makoto Maemondo, Masayuki Takeda, Katsuyuki Hotta, Fumihiko Hirai, Young Hak Kim, Shingo Matsumoto, Masayuki Ito, Koichi Ayukawa, Kota Tokushige, Masataka Yonemura, Testuya Mitsudomi, Makoto Nishio

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9'. Together they form a unique fingerprint.

Medicine & Life Sciences